Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s13058-015-0522-2
| Title: | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy | Authors: | Li, Jingmei Lei, Jieping Rudolph, Anja Moysich, Kirsten Barbara Rafiq, Sajjad Behrens, Sabine Goode, Ellen L. Pharoah, Paul D P Seibold, Petra Fasching, Peter Andreas Ndreas Andrulis, Irene Louise Irene L Kristensen V.N., Couch F.J., Hamann U., Hooning M.J., Nevanlinna H., Eilber U., Bolla M.K., Dennis J., Wang Q., Lindblom A., Mannermaa A., Lambrechts D., Garcia-Closas M., Hall P., Chenevix-Trench G., Shah M., Luben R., Haeberle L., Ekici A.B., Beckmann M.W., Knight J.A., Glendon G., Tchatchou S., Alnaes G.I.G., Borresen-Dale A.-L., Nord S., Olson J.E., Hallberg E., Vachon C., Torres D., Ulmer H.-U., Rudiger T., Jager A., van Deurzen C.H.M., Tilanus-Linthorst M.M.A., Muranen T.A., Aittomaki K., Blomqvist C., Margolin S., Kosma V.-M., Hartikainen J.M., Kataja V., Hatse S., Wildiers H., Smeets A., Figueroa J., Chanock S.J., Lissowska J.,Humphreys K., Phillips K.-A., Linn S., Cornelissen S., van den Broek S.A.J., Kang D., Choi J.-Y., Park S.K., Yoo K.-Y., Hsiung C.-N., Wu P.-E., Hou M.-F., Shen C.-Y., Teo S.H., Taib N.A.M., Yip C.H., Ho G.F., Matsuo K., Ito H., Iwata H., Tajima K., Dunning A.M., Benitez J., Czene K., Sucheston L.E., Maishman T., Tapper W.J., Eccles D., Easton D.F., Schmidt M.K., Chang-Claude J. |
Issue Date: | 2015 | Publisher: | BioMed Central | Citation: | Li, Jingmei, Lei, Jieping, Rudolph, Anja, Moysich, Kirsten Barbara, Rafiq, Sajjad, Behrens, Sabine, Goode, Ellen L., Pharoah, Paul D P, Seibold, Petra, Fasching, Peter Andreas Ndreas, Andrulis, Irene Louise Irene L, Kristensen V.N., Couch F.J., Hamann U., Hooning M.J., Nevanlinna H., Eilber U., Bolla M.K., Dennis J., Wang Q., Lindblom A., Mannermaa A., Lambrechts D., Garcia-Closas M., Hall P., Chenevix-Trench G., Shah M., Luben R., Haeberle L., Ekici A.B., Beckmann M.W., Knight J.A., Glendon G., Tchatchou S., Alnaes G.I.G., Borresen-Dale A.-L., Nord S., Olson J.E., Hallberg E., Vachon C., Torres D., Ulmer H.-U., Rudiger T., Jager A., van Deurzen C.H.M., Tilanus-Linthorst M.M.A., Muranen T.A., Aittomaki K., Blomqvist C., Margolin S., Kosma V.-M., Hartikainen J.M., Kataja V., Hatse S., Wildiers H., Smeets A., Figueroa J., Chanock S.J., Lissowska J.,Humphreys K., Phillips K.-A., Linn S., Cornelissen S., van den Broek S.A.J., Kang D., Choi J.-Y., Park S.K., Yoo K.-Y., Hsiung C.-N., Wu P.-E., Hou M.-F., Shen C.-Y., Teo S.H., Taib N.A.M., Yip C.H., Ho G.F., Matsuo K., Ito H., Iwata H., Tajima K., Dunning A.M., Benitez J., Czene K., Sucheston L.E., Maishman T., Tapper W.J., Eccles D., Easton D.F., Schmidt M.K., Chang-Claude J. (2015). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Research 17 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s13058-015-0522-2 | Source Title: | Breast Cancer Research | URI: | http://scholarbank.nus.edu.sg/handle/10635/127287 | ISSN: | 14655411 | DOI: | 10.1186/s13058-015-0522-2 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
SCOPUSTM
Citations
19
checked on Jan 26, 2023
WEB OF SCIENCETM
Citations
18
checked on Jan 26, 2023
Page view(s)
123
checked on Jan 26, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.